Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours ยท Estimated delivery Aug 8 - Aug 13
Semaglutide: about 14.9% The landmark STEP 1 trial published in the New England Journal of Medicine reported average weight loss of 14.9% at 68 weeks with once-weekly semaglutide 2.4 mg in adults with overweight or obesity, compared with 2.4% for placebo
Skin sensitivity and injection site reactions have been reported at rates comparable to other injectable peptides
Only quantityOfStock item(s) left
They ask all the right questions to support optimal health
US$ 28.97
US$ 25.07
US$ 20.16
US$ 29.08
